Implementation of Red Blood Cell Transfusion Recommendations in the Pediatric Intensive Care Unit

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT07108374
Status
Enrolling By Invitation

Conditions

  • Red Blood Cell Transfusions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Implementation strategies to increase use of transfusion recommendations — OTHER
    Five implementation strategies will be employed in this study to enhance use of the blood transfusion recommendations. These include 1) building consensus, 2) provider education, 3) identifying and empowering champions ,4) use of computerized clinical decision support tools, and 5) provide quantitative metric-based feedback. Strategies 1-3 will occur prior to initiation of CCDS tools. All patients admitted to the PICU following the date of CCDS tool initiation will be considered to be part of the post-implementation phase. The investigators will collect data from the EHR on CCDS use and conduct provider surveys and interviews following CCDS tool initiation. Surveys and interviews will be both be conducted at 6 and 12 months post-CCDS tool initiation. Process and outcomes measures will be assessed before an after use of the implementation strategies.

Study Details

Evidence demonstrates that the risks of red blood cell transfusions outweigh benefits in many patients who are hospitalized in the pediatric intensive care unit with increased risk of organ dysfunction, infection, delirium, and death. Recommendations have been developed to restrict transfusion in patients who are unlikely to benefit; however, these recommendations have not been consistently adopted into clinical practice. This study examines use of targeted efforts (implementation strategies) to improve implementation of the recommendations, with a goal of reducing unnecessary transfusions and improving patient outcomes in critically ill children.

Key Dates

Start date
Nov 30, 2024
Status verified
Jul 2025
Primary completion
Dec 31, 2026
Completion
Feb 1, 2027

Study Design

Enrollment
200 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Primary Outcome Measure

Mean change from baseline in transfusion recommendation adherence at 18 months (evidence-based threshold alert) [ Time Frame: 18 months ]

Locations (2)

FacilityCityStateZIPSite coordinators
Lucile Packard Children's Hospital, Stanford UniversityPalo AltoCalifornia94304-
The Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19104-

Find similar trials in Palo Alto, CA